MR1 and cancer: The singlet receptor MR1 is highly conserved among individuals and binds predominantly to MAIT cells, eliminating the need to design new TCRs for each patient with different cancer types or HLA alleles and natural tropism for specific tissues, which can easily target mucosal tissues such as the liver and gut.